PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

OS Therapies Incorporated

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from OS Therapies Incorporated's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Assets Ratio: Of every $100 the company owns, $5 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than almost all Healthcare companies in United States.
  • Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

—

Data incomplete

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

0/3 · 0/3

Sales and profit both fell in each of the last 3 years.

Less steady than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

—

Data incomplete

Cash Cushion Ratio

—

Data incomplete

Tangible Assets Ratio

5%

Of every $100 the company owns, $5 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than almost all Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+80%

Share count rose 80% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 64% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (7)

OS Therapies Incorporated made a loss over the last year. OS Therapies Incorporated owes $2.20 for every $1 it owns. OS Therapies Incorporated made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

OS Therapies Incorporated made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-4.91

OS Therapies Incorporated's book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$59 M

The total market value of all of OS Therapies Incorporated's shares at today's price (share price × number of shares), smaller than 72% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

Negative

OS Therapies Incorporated's net worth is negative ($12 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.

Owes vs Owns

2.20×

OS Therapies Incorporated owes $2.20 for every $1 it owns, so it owes more than it owns, higher than 97% of Healthcare companies in United States.

Dividend yield

None

OS Therapies Incorporated does not currently pay a dividend.

Profit growth

Loss

OS Therapies Incorporated made a loss in each of the last two years.

Questions

How much does OS Therapies Incorporated owe compared with what it owns?

OS Therapies Incorporated owes $2.20 for every $1 it owns, so it owes more than it owns, higher than 97% of Healthcare companies in United States.

Does OS Therapies Incorporated pay a dividend?

No. OS Therapies Incorporated does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.